OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
47
Results
Show all
Save search
Copy query
Show results for
Unknown
(47)
Publication Date
Release Date
2021
(16)
2025
(7)
2024
(4)
2023
(3)
2022
(3)
2020
(3)
2015
(2)
2014
(2)
2013
(2)
2026
(1)
2017
(1)
2016
(1)
2011
(1)
2009
(1)
Previous
page
1 / 5
You're on page
1
page
2
page
3
page
4
page
5
Next
page
Sort
by:
Relevance
Page size
10
Partial restoration of the microbiota of cesarean-born infants via vaginal microbial transfer.
Not available
S-EPMC5062956
|
biostudies-literature
Cite
Predictive value of pharmacokinetics-adjusted phenotypic susceptibility on response to ritonavir-enhanced protease inhibitors (PIs) in human immunodeficiency virus-infected subjects failing prior PI therapy.
Not available
S-EPMC2687257
|
biostudies-literature
Cite
Combination Treatment with Verinurad and Allopurinol in CKD: A Randomized Placebo and Active Controlled Trial.
Not available
S-EPMC11149044
|
biostudies-literature
Cite
A booster dose of an inactivated SARS-CoV-2 vaccine targeting virus variants sustains protective humoral and cellular immunity.
Not available
S-EPMC12822000
|
biostudies-literature
Cite
Integrative multiomics reveals common endotypes across PSEN1, PSEN2, and APP mutations in familial Alzheimer's disease.
Not available
S-EPMC11699654
|
biostudies-literature
Cite
Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer's disease.
Not available
S-EPMC4159618
|
biostudies-literature
Cite
Psychotropic medication usage in sporadic versus genetic behavioral-variant frontotemporal dementia.
Not available
S-EPMC11848424
|
biostudies-literature
Cite
Drosophila muller f elements maintain a distinct set of genomic properties over 40 million years of evolution.
Not available
S-EPMC4426361
|
biostudies-literature
Cite
Frequency, risk factors, and outcomes of hospital readmissions of COVID-19 patients.
Not available
S-EPMC8253752
|
biostudies-literature
Cite
Safety and Efficacy of Combination SARS-CoV-2 Neutralizing Monoclonal Antibodies Amubarvimab Plus Romlusevimab in Nonhospitalized Patients With COVID-19.
Not available
S-EPMC10150320
|
biostudies-literature
Cite
Previous
page
1 / 5
You're on page
1
page
2
page
3
page
4
page
5
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets